These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16265538)

  • 1. Hypertrophic cardiomyopathy in the community: why we should care.
    Cecchi F; Yacoub MH; Olivotto I
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):324-5. PubMed ID: 16265538
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy is a global disease including China.
    Cheng TO
    Int J Cardiol; 2008 Jun; 127(1):1-4. PubMed ID: 18053599
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy centers.
    Maron BJ
    Am J Cardiol; 2009 Oct; 104(8):1158-9. PubMed ID: 19801041
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy in the developing world: focus on India.
    Maron BJ; Kalra A
    Eur Heart J; 2014 Sep; 35(36):2492-5. PubMed ID: 25038775
    [No Abstract]   [Full Text] [Related]  

  • 5. 'End-stage' hypertrophic cardiomyopathy: from mystery to model.
    Yacoub MH; Olivotto I; Cecchi F
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):232-3. PubMed ID: 17457348
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy in China: three decades of progress.
    Cheng TO
    Int J Cardiol; 2005 Apr; 100(3):493-4. PubMed ID: 15837095
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy in China: from bench to bedside.
    Cheng TO
    Int J Cardiol; 2008 Nov; 130(2):121-4. PubMed ID: 18684519
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy in China.
    Maron BJ
    Am J Cardiol; 2007 Jul; 100(1):145-6. PubMed ID: 17599458
    [No Abstract]   [Full Text] [Related]  

  • 9. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
    Efthimiadis GK; Parcharidou DG; Giannakoulas G; Pagourelias ED; Charalampidis P; Savvopoulos G; Ziakas A; Karvounis H; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2009 Sep; 104(5):695-9. PubMed ID: 19699347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.
    Colan SD; Lipshultz SE; Lowe AM; Sleeper LA; Messere J; Cox GF; Lurie PR; Orav EJ; Towbin JA
    Circulation; 2007 Feb; 115(6):773-81. PubMed ID: 17261650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy.
    Finocchiaro G; Magavern E; Sinagra G; Ashley E; Papadakis M; Tome-Esteban M; Sharma S; Olivotto I
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29237589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiology investigation of colorectal cancer on community group in Guangdong province].
    Xu AG; Jiang B; Yu ZJ; Zhong XH; Gan AH; Liu JH; Luo QY; Xiong LS
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1950-3. PubMed ID: 17923029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy.
    Efthimiadis GK; Giannakoulas G; Parharidou DG; Karvounis HI; Mochlas ST; Styliadis IH; Gavrielides S; Gemitzis KD; Giannoglou GD; Parharidis GE; Louridas GE
    Am J Cardiol; 2006 Nov; 98(9):1269-72. PubMed ID: 17056344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality and disparities reports: why is progress so slow?
    Brady J; Ho K; Clancy CM
    Am J Med Qual; 2008; 23(5):396-8. PubMed ID: 18820145
    [No Abstract]   [Full Text] [Related]  

  • 17. Apical hypertrophic cardiomyopathy and atrial septal defect: part of a multi-organ syndrome?
    Pattoneri P; Pelà G; Astorri E; Borghetti A
    Eur J Echocardiogr; 2007 Jun; 8(3):226-9. PubMed ID: 16542879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community characteristics affecting emergency department use by Medicaid enrollees.
    Lowe RA; Fu R; Ong ET; McGinnis PB; Fagnan LJ; Vuckovic N; Gallia C
    Med Care; 2009 Jan; 47(1):15-22. PubMed ID: 19106726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.